Affiliation:
1. Département de Chimie et Biochimie, Université de Moncton, Moncton, NB E1A 3E9, Canada
2. Atlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada
Abstract
Colorectal cancer (CRC) represents a significant global health burden, with high incidence and mortality rates worldwide. Recent progress in research highlights the distinct clinical and molecular characteristics of colon versus rectal cancers, underscoring tumor location’s importance in treatment approaches. This article provides a comprehensive review of our current understanding of CRC epidemiology, risk factors, molecular pathogenesis, and management strategies. We also present the intricate cellular architecture of colonic crypts and their roles in intestinal homeostasis. Colorectal carcinogenesis multistep processes are also described, covering the conventional adenoma–carcinoma sequence, alternative serrated pathways, and the influential Vogelstein model, which proposes sequential APC, KRAS, and TP53 alterations as drivers. The consensus molecular CRC subtypes (CMS1-CMS4) are examined, shedding light on disease heterogeneity and personalized therapy implications.
Funder
New Brunswick (NB) Innovation Foundation
Canadian Cancer Society
Reference1660 articles.
1. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors;Rawla;Gastroenterol. Rev./Przegląd Gastroenterol.,2019
2. Global colorectal cancer burden in 2020 and projections to 2040;Xi;Transl. Oncol.,2021
3. Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN;Morgan;Gut,2023
4. Risk factors for the diagnosis of colorectal cancer;Lewandowska;Cancer Control,2022
5. O’Sullivan, D.E., Metcalfe, A., Hillier, T.W., King, W.D., Lee, S., Pader, J., and Brenner, D.R. (2020). Combinations of modifiable lifestyle behaviours in relation to colorectal cancer risk in Alberta’s Tomorrow Project. Sci. Rep., 10.